DIA’s Global Pharmacovigilance and Risk Management Strategies Conference 2026
Join UBC at DIA’s Global Pharmacovigilance and Risk Management Strategies Conference, where industry leaders and regulatory experts come together to advance patient safety worldwide. This event provides a critical forum for discussing evolving global regulations, innovative risk management approaches, and best practices in pharmacovigilance.
UBC’s Safety & Risk Management team partners with biopharma organizations to deliver comprehensive pharmacovigilance solutions that ensure compliance and protect patients throughout the product lifecycle. From global case processing and signal detection to risk evaluation and mitigation strategies, we help sponsors navigate complex regulatory landscapes with confidence.
- End-to-End Pharmacovigilance Services: Global case management, aggregate reporting, and signal detection.
- Risk Management Expertise: REMS program design and implementation tailored to regulatory requirements.
- Regulatory Compliance: Proven strategies to meet evolving global safety standards.
- Patient-Centric Approach: Solutions that prioritize safety and transparency.
Connect with our experts during the conference to learn how UBC can support your pharmacovigilance and risk management needs.
Schedule a Meeting
To use these forms you must accept all cookies
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
Trade & Channel Strategies 2026
Operationalise: Early Access Programmes Summit Europe 2026
ASH Annual Meeting 2026
Schedule a Meeting
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.